Evaluating the Effect of Chlorpheniramine on Patch Test Reactions amongst Eczema Patients Sensitised to Nickel
-
Vol. 13 No. 1 : 2018 (71-76)
Abstract
Discontinuing antihistamines for patch testing (PT) in allergic contact dermatitis (ACD) is more conventional than evidence based. Data suggests that non-sedating antihistamines do not interfere with PT. Investigating the effects of sedating antihistamines are more relevant as these are recommended for eczema. We aimed to evaluate the effect of chlorpheniramine on PT, to determine the prevalence of nickel sensitization and common sensitizing allergens. An open labeled cohort study was conducted at two dermatology clinics. Patients indicated for PT underwent standard protocol where antihistamines were discontinued. Patients sensitised to nickel were subjected to a second nickel PT while taking chlorpheniramine. Results were evaluated using the North American Contact Dermatitis Research Group (NACDRG) score, a Mexameter measured erythema and pruritus was assessed using a visual analogue score. A total 82 patients were recruited, 28 (34.1%) were sensitised to nickel. The mean age was 40 ± 17.7 years with 22(26.8%) males and 60 (73.2%) females. Indications for PT included suspected ACD (57.3%), hand and feet eczema (34.1%) and severe eczema with suspected superimposed ACD (6.1%). The commonest sensitizing allergens were methyldibromoglutaronitrile (40.2%) nickel sulphate (34.1%), potassium dichromate (29.3%) and formaldehyde (24.4%). A second PT was performed on 23 patients. There was no difference in the NACDRG score with chlorpheniramine or without chlorpheniramine (p=0.968). Pruritus score was reduced by 1.39 ± 2.9, p=0.031 with chlorpheniramine. The degree of erythema was 611.46 ± 21.59 with chlorpheniramine versus 613.87 ± 27.5 without chlorpheniramine, p=0.671. Chlorpheniramine did not affect PT based on clinical and objective scorings. It has the additional benefit of reducing test-induced itch.
Keywords :
allergic contact dermatitis,
antihistamine,
patch test,
Correspondance Address
Adawiyah Jamil. Department of Medicine, Faculty of
Medicine, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, 56000
Cheras, Kuala Lumpur, Malaysia. Tel: +603-91456074 E-mail: adda_jamil@yahoo.com
References
Akasya-Hillenbrand, E., Ozkaya-Bayazit, E. 2002.
Patch test results in 542 patients with suspected
contact dermatitis in Turkey. Contact Dermatitis
46(1): 17-23.
Arkwright, P.D., Motala, C., Subramanian, H.,
Spergel, J., Schneider, L.C., Wollenberg, A.
2013. Management of difficult to treat atopic
dermatitis. J Allergy Clin Immunol Pract 1(2):
142-51.
Brasch, J., Henseler, T., Aberer, W., Bäuerle, G.,
Frosch, P.J., Fuchs, T., Fünfstück, V., Kaiser, G.,
Lischka, G.G., Pilz, B. 1994. Reproducibility of
patch tests: a multicenter study of synchronous
left versus right sided patch tests by the German
Contact Dermatitis Research Group. J Am Acad
Derm 31(4): 584-91.
Canonica, G.W., Blaiss, M. 2011. Antihistaminic, antiinflammatory,
and antiallergic properties of the
nonsedating second-generation antihistamine
desloratadine: A review of the evidence. World
Allergy Organ J 4(2): 47-53.
Chen, X.J., Chen, L.L., Shi, X., Xie, L.X., Leng, H., Ji,
J., Lu, D.D. 2012. The effect of desloratadine on
patch test reactions in Chinese patients. Asian
Pac J Immunol 30(3): 209-13.
DeKoven, J.G., Warshaw, E.M., Belsito, D.V.,
Sasseville, D., Maibach, H.I., Taylor, J.S., Marks,
J.G., Fowler, J.F., Mathias, C.G., DeLeo, V.A.,
Pratt, M.D., Zirwas, M.J., Zug, K.A. 2017. North
American Contact Dermatitis Group Patch Test
Results 2013-2014. Dermatitis 28(1): 33-46.
Fonacier, L., Bernstein, D.I., Pacheco, K., Holness,
D.L., Blessing-Moore, J., Khan, D., Lang, D.,
Nicklas, R., Oppenheimer, J., Portnoy, J.,
Randolph, C., Schuller, D., Spector, S., Tilles, S.,
Wallace, D. 2015. Contact dermatitis: a practice
parametere update 2015. J Allergy Clin Immunol
Pract 3(3 Suppl): S1-S39.
Grob, J.J., Castelain, M., Richard, M.A., Bonniol, J.P.,
Beraud, V., Adhoute, H., Guillou, N., Bonerandi,
J.J. 1998. Anti-inflammatory properties of
cetirizine in a human contact dermatitis model.
Clinical evaluation of patch test is not hampered
by antihistamines. Acta Derm Venereol 78(3):
194-7.
Leok, J.T., Goh, C.L., Ng, S.K., Wong, W.K. 1992.
Changing trends in the epidemiology of contact
dermatitis in Singapore. Contact Dermatitis
26(5): 321-6.
Li, P., Sun, X.D., Shi, X., Cai, Y.L., Zhang, J., Chen, X.J.,
Chen, L.L., Xie, L.X. 2011. Influences on skin
patch test reaction in Chinese due to Loratadine
in conventional dose. Chin J Dermatol 11: 765-
7.
Memon, A.A., Friedman, P.S. 1996. Studies on the
reproducibility of allergic contact dermatitis. Br
J Dermatol 134(2): 208-14.
Motolese, A., Ferdani, G., Manzini B.M., Seidenari,
S. 1995. Echographic evaluation of patch
test inhibition by oral antihistamine. Contact
Dermatitis 32(4): 250-1.
Rodrigues, D.F., Goulart, E.M. 2016. Patch-test results
in children and adolescents: systematic review
of a 15-year period. An Bras Dermatol 91(1): 64-
72.
Vena, G.A., Cassano, N., Buquicchio, R., Ventura,
M.T. 2008. Antiinflammatory effects of H1-
antihistamines: clinical and immunological
relevance. Curr Pharm Des 14(27): 2902-11.
Yee, V.S., Rohana, R. 2013. Patch testing with
preservative sensitizers. A year retrospective
study from Selayang Hospital. Malaysian J Derm
30; 1-6.
Yim, E., Baquerizo Nole, K.L., Tosti, A. 2014. Contact
dermatitis caused by preservatives. Dermatitis
25(5): 215-31.
